Journal of Internet Computing and Services (인터넷정보학회논문지)

Korean Society for Internet Information (한국인터넷정보학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Usefulness of the Protein Drug Feature Information Filed

단백질 의약품 특성정보필드 유용성 평가

  • Byeon, Jaehee (Dept. of Stereoscopic Media, Korean German Institute of Technology) ;
  • Choi, Yoo-Joo (Dept. of Newmedia, Korean German Institute of Technology) ;
  • Lee, Ju-Hwan (Dept. of Newmedia, Korean German Institute of Technology) ;
  • Suh, Jung-Keun (Dept. of Newmedia, Korean German Institute of Technology)
  • Received : 2014.02.07
  • Accepted : 2014.05.14
  • Published : 2014.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

As the protein drug industry is growing, protein informations are indispensable for the protein drug development. NCBI and PDB in the U.S., the EMBL in Europe and the DDBJ in Japan are the representative centers for bio information and each center provides specific data for protein information. To obtain specific protein information, users are to be collect them from the service sites of each center and then combine or analyze for their purpose. To facilitate the accessibility to bio data, various R&D activities are running for development of diverse web services relevant to bio data in major data centers or small-scale projects. With the recognition of protein information as pivotal for the protein drug development, DrugBank in Canada, GDSC in the U.S. start to provide integrated informations between drugs and proteins. However, those service does not meet users' demands due to lack of diversity. In Korea, infra structures for bioinformatics are limited and the current services for protein drug information are providing only basic information of the drug including distribution data. This is a pilot study to construct a specialized service for protein drug information in Korean style breaking through the limitations of current services. This study proposed new fields for protein characterization information which had not been provided by current services and evaluated their effectiveness and usability by comparing them to the existing fields with expert survey. As a result, the newly proposed fields for protein characterization have been proven to be useful data fields for the service of protein drug information.

단백질 의약품 산업이 성장함에 따라 단백질 의약품 개발 시 단백질 정보는 필수적으로 인식 되고 있다. 단백질 정보 서비스를 제공하는 대표적인 바이오데이터 센터로는 미국의 NCBI, PDB, 유럽의 EMBL, 일본의 DDBJ 등이 있으며, 각 센터별로 특화된 단백질 정보들이 제공되고 있다. 사용자가 원하는 단백질 정보를 얻기 위해서는 독립된 단백질 정보를 검색하고 이를 통합하고 분석해야하며, 보다 편리하게 접근할 수 있도록 대표적인 데이터 센터 혹은 소규모 프로젝트 별로 바이오데이터에 대한 다양한 웹서비스가 연구 개발되고 있다. 단백질 의약품 정보 서비스에 대한 필요성이 높아지면서 캐나다의 DrugBank, 미국의 GDSC 등에서 의약품 정보와 단백질 데이터를 통합하여 서비스하고 있다. 하지만 사용자가 요구하는 다양한 단백질 정보를 반영하지 못하는 실정이다. 국내의 경우 바이오인포매틱스 인프라가 부족하고, 단백질 의약품 정보 서비스 또한 의약품의 기본 정보와 유통정보만을 제공하는 것에 한정되어 있다. 본 연구에서는 기존 서비스의 한계를 벗어난 한국형 단백질 의약품 전용 서비스 설계를 위한 사전 연구로 기존 대표적 데이터베이스에서는 적용하고 있지 않은 단백질 특성정보필드들을 제시하고 이에 대한 유용성 평가를 전문 종사자를 대상으로 진행하여 기존 바이오데이터베이스의 단백질 정보 필드와 비교하였다. 그 결과 본 연구에서 제시한 단백질 특성정보필드들이 단백질 의약품 정보 서비스에 요구되는 유용한 데이터 필드임을 검증하였다.

Keywords

References

  1. H. Y. Jung, S. J. Park, and S. H. Park, "Bioinformatics Technology," Electronics and Telecommunications Trends, Vol. 20, No. 5, 2005, pp. 93-104.
  2. S. J. Lee, H. S. Yong, "Development of Integrated Retrieval System of the Biology Sequence Database Using 11 Service," The KIPS Transactions:PartD, Vol. 11D, No. 4, 2004, pp. 755-764. https://doi.org/10.3745/KIPSTD.2004.11D.4.755
  3. D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. Chang, and J. Woolsey, "DrugBank: a comprehensive resource for in silico drug discovery and exploration," Nucleic Acids Research, Vol. 34, 2006, pp, D668-D672. https://doi.org/10.1093/nar/gkj067
  4. B. Y. Ahn, J. M. Han, and S. C. Hong, "Design of Integrated Retrieval System for Bioinformatics," 2007 KoCon Autumn Comprehensive Academy Conference, Vol. 5, No. 1, 2007, pp. 11-14.
  5. D. H. Im, "Trends of Bioinformatics for Establishing a Science-Technology-Oriented Society in the 21st Century," Graduate School of Sejong University, Master's thesis, 2004.
  6. Y. H. Choi, "Implementation of WSBAT: 11 Services based Biodata Analysis Tool," Graduate School of Sejong University, Master's thesis, 2004.
  7. B. A. Aksoy, J. Gao, G. Dresdner, W. Wang, A. Root, X. Jing, E. Cerami, and C. Sander, "PiHelper: An Open Source Framework for Drug-Target and Antibody-Target Data," Bioinformatics, 2013.
  8. W. Yang, J. Soares, P. Greninger, E. J. Edelman, H. Lightfoot, S. Forbes, N. Bindal, D. Beare, J. A. Smith, I. R. Thompson, S. Ramaswamy, P. A. Futreal, D. A. Haber, M. R. Stratton, C. Benes, U. McDermott, and M. J. Garnett, "Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells," Nucleic Acids Research, Vol. 41, 2013, pp. D955-D961. https://doi.org/10.1093/nar/gks1111
  9. J. S. Sohn, D. H. Kim, and I. J. Chung, "Representation of drug informations and their relations using ontology," Proceeding of Korea Computer Congress , Vol. 37, No. 1(C), 2010, pp. 317-322.
  10. H. S. Jung, B. R. Hyun, S. H. Jung, W. H. Jang, and D. S. Han, "Drug Target Protein Prediction using SVM," KISS Korea Computer Congress, Vol. 34, No. 2(B), 2007, pp. 17-21.
  11. Korea Pharmaceutical Information Service, http://www.kpis.or.kr/
  12. NCBI Resource Coordinators, "Database resources of the National Center for Biotechnology Information," Nucleic Acids Research, Vol. 41, 2013, pp. D8-D20. https://doi.org/10.1093/nar/gks1189
  13. EMBL, http://www.embl.org/
  14. P. W. Rose, C. Bi, W. F, Bluhm, C. H. Christie, D. Dimitropoulos, S. Dutta, R. K, Green, D. S. Goodsell, A. Prlic, M. Quesada, G. B. Quinn, A. G. Ramos, J. D. Westbrook, J. Young, C. Zardecki, H. M. Berman, and P. E. Bourne, "The RCSB Protein Data Bank: new resources for research and education," Nucleic Acids Research, Vol. 41, 2013, pp. D475-D482. https://doi.org/10.1093/nar/gks1200
  15. Guideline on Characterisation and Specifications for Therapeutic Monoclonal Antibody Products. 2011. Korea Food and Drug Administration.
  16. ICH Q6B "Test Procedures and Acceptance Criteria for Biotechnological/Biological Products" (CPMP/ICH/365/96). 1999. European Medicines Agency.
  17. Guideline on Development, Production, Characterization and Specifications for Monoclonal Antibodies and Related Products. 2009. European Medicines Agency.
  18. D. K. Han, "A study on the media of bio-information based on 3D modeloing for protein tertiary structure," Korean German Institute of Technology, Master's thesis, 2012.
  19. J. H. Byeon, Y. J. Choi, J. H. Lee, and J. K. Suh, "The Present Situation Analysis on Services of Protein Drug Information," Proceedings of the Korea Information Processing Society Conference, 2014.

Cited by

  1. Evaluation of Information Representation Goodness-of-fit According to Protein Visualization Pattern vol.16, pp.2, 2015, https://doi.org/10.7472/jksii.2015.16.2.117